These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 2484784)

  • 61. Arachidonic acid of platelet phospholipids is decreased after extracorporeal removal of plasma low density lipoproteins in patients with familial hypercholesterolemia.
    Bräutigam R; Bräutigam C; Lorenz R; Richter WO; Engelmann B
    Atherosclerosis; 1997 May; 131(1):97-106. PubMed ID: 9180250
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Comparison of dextran sulphate cellulose and double filtration plasmaphereses for the treatment of severe hypercholesterolemia.
    Franceschini G; Calabresi L; Vaccarino V; Busnach G; Cappelleri A; Sirtori CR
    Beitr Infusionsther; 1988; 23():112-7. PubMed ID: 2484764
    [No Abstract]   [Full Text] [Related]  

  • 63. A novel system of LDL apheresis combining a centrifugal plasma separator with a specific LDL adsorption column.
    Nakajima T; Nakamura T; Funahashi T; Kanai H; Kurata Y; Matsuzawa Y; Tarui S
    Atherosclerosis; 1988 Oct; 73(2-3):143-8. PubMed ID: 3190816
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Long term result of LDL selective plasma adsorption therapy on familial hypercholesterolemia.
    Odaka M; Kobayashi H; Tabata Y; Soeda K; Hayashi H; Ito S; Murotani N; Saito Y; Nishide T; Shinomiya M
    Biomater Artif Cells Artif Organs; 1987; 15(1):113-24. PubMed ID: 3449131
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Comparative evaluation of a heparin-citrate anticoagulation for LDL-apheresis in two primary apheresis systems.
    Handschel D; Etienne Janssens M; Gericke M; De Reys S; Borberg H
    J Clin Apher; 2017 Oct; 32(5):319-328. PubMed ID: 27676234
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Decrease of thyroid hormones in patients with familial hypercholesterolemia during dextran sulphate low-density lipoprotein apheresis.
    Pintus S; Pintus P; Piras C; Loviselli A; Muntoni S
    J Clin Apher; 1994; 9(2):124-5. PubMed ID: 7798159
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Severe dyslipidemia in pregnancy: The role of therapeutic apheresis.
    Russi G
    Transfus Apher Sci; 2015 Dec; 53(3):283-7. PubMed ID: 26626968
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Effect of LDL-apheresis on the pharmacokinetics of the lipophilic antilipidemic agent probucol.
    Komura T; Takahara K; Sugano M; Fujinishi A; Tasaki H; Nakashima Y; Kuroiwa A
    Eur J Drug Metab Pharmacokinet; 1997; 22(3):201-6. PubMed ID: 9358199
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Adsorption of lipoprotein containing apolipoprotein-B through plasma separation for treatment of familial hypercholesterolemia.
    Odaka M; Kobayashi H; Soeda K; Murotani N; Saito Y; Nishide T; Yoshida S; Tani N; Takata S
    Int J Artif Organs; 1986 Sep; 9(5):343-8. PubMed ID: 3781667
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Treatment of familial hypocholesterolemia by means of specific immunoadsorption.
    Borberg H; Gaczkowski A; Hombach V; Oette K; Stoffel W
    J Clin Apher; 1988; 4(2-3):59-65. PubMed ID: 3294230
    [No Abstract]   [Full Text] [Related]  

  • 71. Thermofiltration in hypercholesterolemia treatment: analysis of removal and posttreatment cholesterol recovery.
    Malchesky PS; Werynski A; Nomura H; Takeyama Y; Yamashita M; Nosè Y
    J Clin Apher; 1990; 5(3):145-50. PubMed ID: 2345162
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Long-term plasmapheresis in the management of severe hypercholesterolemia.
    Keller C; Zöllner N
    Beitr Infusionsther; 1988; 23():81-6. PubMed ID: 2484786
    [No Abstract]   [Full Text] [Related]  

  • 73. Heparin-sorbent for low density lipoproteins removal in hypercholesterolemia.
    Sinitsyn VV; Metlitscaya LM; Mamontova AG; Konovalov GA; Kukharchuk VV
    Biomater Artif Cells Artif Organs; 1990; 18(5):629-35. PubMed ID: 2099218
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Changes in HCV viremia following LDL apheresis in a HCV positive patient with familial hypercholesterolemia.
    Marson P; Boschetto R; De Silvestro G; Martini S; Gabelli C; Buoro S; Giordano R; Palù G
    Int J Artif Organs; 1999 Sep; 22(9):640-4. PubMed ID: 10532434
    [TBL] [Abstract][Full Text] [Related]  

  • 75. LDL-apheresis: results of longterm treatment and vascular outcome.
    Keller C
    Atherosclerosis; 1991 Jan; 86(1):1-8. PubMed ID: 2064631
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The current status of low-density lipoprotein apheresis.
    Borberg H; Kadar J; Oette K
    Curr Stud Hematol Blood Transfus; 1990; (57):239-48. PubMed ID: 2272204
    [No Abstract]   [Full Text] [Related]  

  • 77. LDL-apheresis improves microalbuminuria in patients with severe familial heterozygous hypercholesterolemia.
    Sinzinger H; Kritz H
    Atherosclerosis; 1999 Mar; 143(1):223-4. PubMed ID: 10208501
    [No Abstract]   [Full Text] [Related]  

  • 78. Reduction of Lp(a) by different methods of plasma exchange.
    Schenck I; Keller C; Hailer S; Wolfram G; Zöllner N
    Klin Wochenschr; 1988 Dec; 66(24):1197-201. PubMed ID: 2976858
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Evaluation of albumin loss during low-density lipoprotein apheresis.
    Kojima S; Shiba M; Nomura S; Kimura G; Tsushima M; Kuramochi M; Yamamoto A; Omae T
    ASAIO Trans; 1990; 36(4):830-3. PubMed ID: 2268488
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Treatment of severe hypercholesterolemia by heparin-induced extracorporeal LDL precipitation (HELP).
    Schuff-Werner P; Armstrong VW; Eisenhauer T; Thiery J; Seidel D
    Beitr Infusionsther; 1988; 23():118-26. PubMed ID: 2484765
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.